🔎 Trials Near Me

Home › Breast Cancer › NCT06105749

Biennial CEM in Women With a Personal History of Breast Cancer

RecruitingHealthy volunteers welcome

Outcome of Biennial Screening Contrast-Enhanced Mammography (CEM) in Women With a Personal History of Breast Cancer (PHBC)

Who can join

Ages 30 to 79 · Women · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Asymptomatic women, ages 30-79, with a personal history of breast cancer who are at least one year out from any breast cancer surgery and/or treatment and are scheduled to have a routine annual mammogram with tomosynthesis (DBT).

Exclusion Criteria:

* Women with a history of prior moderate or severe iodinated contrast reaction \[only those with a prior mild reaction that can be managed by pre-medication AND with and a strong desire to participate will be allowed to participate. However, among these women with a mild sensitivity, if they are allergic to Benadryl (one of the premedications), they will be excluded\].
* Women with implant(s) in the breasts to be screened (as this creates artifacts and diagnostic performance of imaging in women with implants likely does not generalize to those without implants, and the sample size with implants would be too small to infer conclusions.
* Women who have had bilateral mastectomy
* Women with a history of kidney failure or estimated glomerular filtration rate (eGFR) \< 30 mL/min
* Pregnancy or lactation
* Women actively being treated for cancer of any type with chemotherapy.
* Women with stage 4 metastasis to visceral areas or brain
* Women with known personal history of breast cancer who have a screening breast MRI exam within 24 months prior to the current round of CEM.
* Women with known personal history of breast cancer who had a CEM exam within the prior 23 months

About the study

This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.

What is being tested

Sponsor: Wendie Berg · Participants: 1,600 · Started: Nov 8, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT06105749

Locations in the U.S.

PennsylvaniaUPMC Magee-Womens Imaging - Bethel Park, Bethel Park
UPMC Magee at the Lemieux Sports Complex, Cranberry Township
Magee Womancare Monroeville, Monroeville
Hillman Cancer Center at Shadyside, Pittsburgh
Magee-Womens Hospital, Pittsburgh
UPMC West Mifflin Outpatient Center, West Mifflin

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.